Oramed's oral insulin succeeds in study, shares jump

[riky]

Oramed's oral insulin succeeds in study, shares jump

(Reuters) - Oramed Pharmaceuticals Inc said its oral insulin capsule appeared to be safe and was well-tolerated by diabetics in a mid-stage trial. The Israeli biotechnology company's shares jumped about 10 percent to $8.73 before the bell on Wednesday. The treatment, ORMD-0801, was being tested in 25 patients with type 1 diabetes, once known as juvenile diabetes. It is a chronic condition in which the pancreas produces little or no insulin, a hormone needed to allow sugar to enter cells to produce energy. ...

Source: You are not allowed to view links. Register or Login